Preoperative staging of non-small-cell lung cancer with positron-emission tomography.
暂无分享,去创建一个
H. Groen | J. Pruim | W. Vaalburg | V. Fidler | G. Koëter | R. Pieterman | J. V. van Putten | J. Meuzelaar | E. Mooyaart | H. Groen | J. Meuzelaar | E. Mooyaart | G. Köeter | Vaclav Fidler
[1] M. Mandelkern,et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. , 1996, American journal of respiratory and critical care medicine.
[2] P. Lewis,et al. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] G. V. von Schulthess,et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. , 1998, The Annals of thoracic surgery.
[4] J Bogaert,et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] P. Dupont,et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[7] T Jones,et al. Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.
[8] M E Phelps,et al. Whole-body positron emission tomography: Part I. Methods and performance characteristics. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] G. V. von Schulthess,et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.
[10] R L Wahl,et al. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] J. Reed,et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. , 1995, American journal of respiratory and critical care medicine.
[12] P. Rigo,et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer , 1998, European Journal of Nuclear Medicine.
[13] R. Wahl,et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.
[14] C. Mountain,et al. Regional lymph node classification for lung cancer staging. , 1997, Chest.
[15] M. Defrise,et al. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction , 1999, European Journal of Nuclear Medicine.
[16] F. Maes,et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? , 1998, European Journal of Nuclear Medicine.
[17] M P Frick,et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.
[18] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] T Ido,et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] P. Valk,et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.
[21] R. Coleman,et al. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.
[22] K Kubota,et al. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.